BGB-3111-112

Completed

The Effect of Moderate CYP3A Inducer Rifabutin on the Pharmacokinetics of Zanubrutinib in Healthy Males

Beigene Study ID info

BGB-3111-112

ClinicalTrials.gov ID info

Study Overview

Sex: Male

Age: 18 Years to 65 Years (Adult, Older Adult)

Accepts Healthy Volunteers? yes

No Study Documents

Study Overview

Sex: Male

Age: 18 Years to 65 Years (Adult, Older Adult)

Accepts Healthy Volunteers? yes

No Study Documents